Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2003 Jul;163(1):373-5; author reply 375-6.
doi: 10.1016/s0002-9440(10)63664-4.

Class II transactivator (CIITA) deficiency in tumor cells: complicated mechanisms or not?

Peter J van den Elsen, Nienke van der Stoep
Comment

Class II transactivator (CIITA) deficiency in tumor cells: complicated mechanisms or not?

Peter J van den Elsen et al. Am J Pathol. 2003 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
RT-PCR analysis on IFN-γ-inducible expression of promoter III-derived (Pro III) and promoter IV-derived (Pro IV) CIITA (38 cycles of PCR) and GAPDH (28 cycles of PCR) in small cell lung cancer (SCLC), neuroblastoma (NB), and non-SCLC cell lines. Cultured cancer cells were treated with 500 units/ml IFN-γ for 24 hours.
See this image and copyright information in PMC

Comment on

References

    1. Yazawa T, Ito T, Kamma H, Suzuki T, Okudela K, Hayashi H, Horiguchi H, Ogata T, Mitsui H, Ikeda M, Kitamura H: Complicated mechanisms of class II transactivator transcription deficiency in small cell lung cancer and neuroblastoma. Am J Pathol 2002, 161:291-300 - PMC - PubMed
    1. Ostrand-Rosenberg S, Thakur A, Clements V: Rejection of mouse sarcoma cells after transfection of MHC class II genes. J Immunol 1990, 144:4068-4071 - PubMed
    1. Kamma H, Fujii K, Ogata T: Lymphocytic infiltration in juvenile thyroid carcinoma. Cancer 1988, 62:1988-1993 - PubMed
    1. Yazawa, Kamma H, Ogata T: Frequent expression of HLA-DR antigen in medullary carcinoma of the breast: a possible reason for its prominent lymphocytic infiltration and favorable prognosis. Appl Immunohistochem 1993, 1:289-296
    1. Yazawa T, Kamma H, Fujiwara M, Matsui M, Horiguchi H, Satoh H, Fujimoto M, Yokoyama K, Ogata T: Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer. J Pathol 1999, 187:191-199 - PubMed

LinkOut - more resources